| UniProt ID | NOL11_HUMAN | |
|---|---|---|
| UniProt AC | Q9H8H0 | |
| Protein Name | Nucleolar protein 11 | |
| Gene Name | NOL11 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 719 | |
| Subcellular Localization | Nucleus, nucleolus . | |
| Protein Description | Ribosome biogenesis factor. May be required for both optimal rDNA transcription and small subunit (SSU) pre-rRNA processing at sites A', A0, 1 and 2b.. | |
| Protein Sequence | MAALEEEFTLSSVVLSAGPEGLLGVEQSDKTDQFLVTDSGRTVILYKVSDQKPLGSWSVKQGQIITCPAVCNFQTGEYVVVHDNKVLRIWNNEDVNLDKVFKATLSAEVYRILSVQGTEPLVLFKEGAVRGLEALLADPQQKIETVISDEEVIKWTKFFVVFRHPVLIFITEKHGNYFAYVQMFNSRILTKYTLLLGQDENSVIKSFTASVDRKFISLMSLSSDGCIYETLIPIRPADPEKNQSLVKSLLLKAVVSGNARNGVALTALDQDHVAVLGSPLAASKECLSVWNIKFQTLQTSKELPQGTSGQLWYYGEHLFMLHGKSLTVIPYKCEVSSLAGALGKLKHSQDPGTHVVSHFVNWETPQGCGLGFQNSEQSRRILRRRKIEVSLQPEVPPSKQLLSTIMKDSEKHIEVEVRKFLALKQTPDFHTVIGDTVTGLLERCKAEPSFYPRNCLMQLIQTHVLSYSLCPDLMEIALKKKDVQLLQLCLQQFPDIPESVTCACLKIFLSIGDDSLQETDVNMESVFDYSINSVHDEKMEEQTEILQNGFNPEEDKCNNCDQELNKKPQDETKESTSCPVVQKRAALLNAILHSAYSETFLLPHLKDIPAQHITLFLKYLYFLYLKCSENATMTLPGIHPPTLNQIMDWICLLLDANFTVVVMMPEAKRLLINLYKLVKSQISVYSELNKIEVSFRELQKLNQEKNNRGLYSIEVLELF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 23 | Ubiquitination | SAGPEGLLGVEQSDK CCCCCCCCCCCCCCC | 12.12 | - | |
| 42 | Phosphorylation | LVTDSGRTVILYKVS EECCCCCEEEEEEEC | 18.54 | 20068231 | |
| 46 | Phosphorylation | SGRTVILYKVSDQKP CCCEEEEEEECCCCC | 9.75 | 20068231 | |
| 47 | Ubiquitination | GRTVILYKVSDQKPL CCEEEEEEECCCCCC | 31.64 | 22817900 | |
| 49 | Phosphorylation | TVILYKVSDQKPLGS EEEEEEECCCCCCCC | 30.12 | - | |
| 52 | Acetylation | LYKVSDQKPLGSWSV EEEECCCCCCCCCEE | 47.39 | 26051181 | |
| 52 | Ubiquitination | LYKVSDQKPLGSWSV EEEECCCCCCCCCEE | 47.39 | 21890473 | |
| 52 | Ubiquitination | LYKVSDQKPLGSWSV EEEECCCCCCCCCEE | 47.39 | 21906983 | |
| 58 | Phosphorylation | QKPLGSWSVKQGQII CCCCCCCEEECCEEE | 22.57 | - | |
| 59 | Ubiquitination | KPLGSWSVKQGQIIT CCCCCCEEECCEEEE | 4.34 | 23503661 | |
| 65 | Ubiquitination | SVKQGQIITCPAVCN EEECCEEEEECEEEE | 2.20 | - | |
| 65 | Ubiquitination | SVKQGQIITCPAVCN EEECCEEEEECEEEE | 2.20 | 22817900 | |
| 70 | Ubiquitination | QIITCPAVCNFQTGE EEEEECEEEECCCCC | 1.33 | - | |
| 70 | Ubiquitination | QIITCPAVCNFQTGE EEEEECEEEECCCCC | 1.33 | 22817900 | |
| 85 | Acetylation | YVVVHDNKVLRIWNN EEEEECCEEEEEECC | 49.02 | 26051181 | |
| 99 | Ubiquitination | NEDVNLDKVFKATLS CCCCCHHHHHHHHHH | 53.38 | 21906983 | |
| 99 | Acetylation | NEDVNLDKVFKATLS CCCCCHHHHHHHHHH | 53.38 | 25825284 | |
| 102 | Ubiquitination | VNLDKVFKATLSAEV CCHHHHHHHHHHHHH | 43.37 | 22817900 | |
| 114 | Phosphorylation | AEVYRILSVQGTEPL HHHHHHHHCCCCCCE | 15.26 | - | |
| 125 | Ubiquitination | TEPLVLFKEGAVRGL CCCEEEEECCHHHHH | 51.59 | 23000965 | |
| 125 | Ubiquitination | TEPLVLFKEGAVRGL CCCEEEEECCHHHHH | 51.59 | 21890473 | |
| 125 | Acetylation | TEPLVLFKEGAVRGL CCCEEEEECCHHHHH | 51.59 | 25825284 | |
| 142 | Ubiquitination | LLADPQQKIETVISD HHCCHHHHEEEECCH | 36.94 | 29967540 | |
| 145 | Phosphorylation | DPQQKIETVISDEEV CHHHHEEEECCHHHH | 26.98 | 21406692 | |
| 148 | Phosphorylation | QKIETVISDEEVIKW HHEEEECCHHHHHHH | 34.33 | 21406692 | |
| 162 | Ubiquitination | WTKFFVVFRHPVLIF HHEEEEEEECCEEEE | 5.09 | - | |
| 162 | Ubiquitination | WTKFFVVFRHPVLIF HHEEEEEEECCEEEE | 5.09 | 29967540 | |
| 164 | Ubiquitination | KFFVVFRHPVLIFIT EEEEEEECCEEEEEE | 12.83 | - | |
| 186 | Phosphorylation | AYVQMFNSRILTKYT EEEEECCHHHCHHHH | 14.94 | - | |
| 191 | Acetylation | FNSRILTKYTLLLGQ CCHHHCHHHHECCCC | 32.56 | 26051181 | |
| 205 | Ubiquitination | QDENSVIKSFTASVD CCCCHHHHHEEEECC | 37.04 | - | |
| 206 | Phosphorylation | DENSVIKSFTASVDR CCCHHHHHEEEECCH | 19.39 | 21406692 | |
| 208 | Phosphorylation | NSVIKSFTASVDRKF CHHHHHEEEECCHHH | 25.72 | 21406692 | |
| 210 | Phosphorylation | VIKSFTASVDRKFIS HHHHEEEECCHHHHH | 22.84 | 21406692 | |
| 217 | Ubiquitination | SVDRKFISLMSLSSD ECCHHHHHHEEECCC | 22.58 | 29967540 | |
| 225 | Ubiquitination | LMSLSSDGCIYETLI HEEECCCCCEEEEEE | 11.15 | - | |
| 229 | Ubiquitination | SSDGCIYETLIPIRP CCCCCEEEEEEECCC | 19.75 | - | |
| 237 | Ubiquitination | TLIPIRPADPEKNQS EEEECCCCCHHHCHH | 34.83 | - | |
| 237 | Ubiquitination | TLIPIRPADPEKNQS EEEECCCCCHHHCHH | 34.83 | 22817900 | |
| 241 | Ubiquitination | IRPADPEKNQSLVKS CCCCCHHHCHHHHHH | 66.72 | 23503661 | |
| 242 | Ubiquitination | RPADPEKNQSLVKSL CCCCHHHCHHHHHHH | 34.70 | 21963094 | |
| 242 | Ubiquitination | RPADPEKNQSLVKSL CCCCHHHCHHHHHHH | 34.70 | - | |
| 247 | Ubiquitination | EKNQSLVKSLLLKAV HHCHHHHHHHHHHHH | 40.45 | 21906983 | |
| 247 | Acetylation | EKNQSLVKSLLLKAV HHCHHHHHHHHHHHH | 40.45 | 26051181 | |
| 252 | Ubiquitination | LVKSLLLKAVVSGNA HHHHHHHHHHHCCCC | 38.82 | 22817900 | |
| 263 | Ubiquitination | SGNARNGVALTALDQ CCCCCCCEEEEEECC | 4.50 | - | |
| 283 | Phosphorylation | LGSPLAASKECLSVW ECCCCHHCHHHHHHH | 24.31 | 27050516 | |
| 344 | Acetylation | SLAGALGKLKHSQDP HHHHHHHCCCCCCCC | 56.03 | 25953088 | |
| 344 | Ubiquitination | SLAGALGKLKHSQDP HHHHHHHCCCCCCCC | 56.03 | 29967540 | |
| 346 | Ubiquitination | AGALGKLKHSQDPGT HHHHHCCCCCCCCCC | 44.70 | - | |
| 346 | Methylation | AGALGKLKHSQDPGT HHHHHCCCCCCCCCC | 44.70 | 24129315 | |
| 374 | Ubiquitination | GCGLGFQNSEQSRRI CCCCCCCCHHHHHHH | 45.30 | - | |
| 374 | Ubiquitination | GCGLGFQNSEQSRRI CCCCCCCCHHHHHHH | 45.30 | 21963094 | |
| 384 | Ubiquitination | QSRRILRRRKIEVSL HHHHHHHHCCCEEEE | 40.58 | 33845483 | |
| 385 | Ubiquitination | SRRILRRRKIEVSLQ HHHHHHHCCCEEEEC | 37.56 | 27667366 | |
| 390 | Phosphorylation | RRRKIEVSLQPEVPP HHCCCEEEECCCCCC | 14.43 | - | |
| 391 | Ubiquitination | RRKIEVSLQPEVPPS HCCCEEEECCCCCCH | 13.71 | 27667366 | |
| 399 | Ubiquitination | QPEVPPSKQLLSTIM CCCCCCHHHHHHHHH | 51.22 | 29967540 | |
| 401 | Ubiquitination | EVPPSKQLLSTIMKD CCCCHHHHHHHHHHC | 4.72 | 27667366 | |
| 401 | Ubiquitination | EVPPSKQLLSTIMKD CCCCHHHHHHHHHHC | 4.72 | - | |
| 403 | Phosphorylation | PPSKQLLSTIMKDSE CCHHHHHHHHHHCCH | 25.20 | 20860994 | |
| 404 | Phosphorylation | PSKQLLSTIMKDSEK CHHHHHHHHHHCCHH | 25.67 | 20860994 | |
| 407 | Ubiquitination | QLLSTIMKDSEKHIE HHHHHHHHCCHHCEE | 55.01 | - | |
| 409 | Phosphorylation | LSTIMKDSEKHIEVE HHHHHHCCHHCEEHH | 42.92 | 20860994 | |
| 411 | Acetylation | TIMKDSEKHIEVEVR HHHHCCHHCEEHHHH | 54.56 | 26051181 | |
| 411 | Ubiquitination | TIMKDSEKHIEVEVR HHHHCCHHCEEHHHH | 54.56 | - | |
| 419 | Ubiquitination | HIEVEVRKFLALKQT CEEHHHHHHHHHHCC | 50.32 | 22817900 | |
| 424 | Acetylation | VRKFLALKQTPDFHT HHHHHHHHCCCCCCH | 46.66 | 26051181 | |
| 424 | Ubiquitination | VRKFLALKQTPDFHT HHHHHHHHCCCCCCH | 46.66 | 21906983 | |
| 445 | Ubiquitination | TGLLERCKAEPSFYP HHHHHHHCCCCCCCC | 63.10 | - | |
| 494 | Ubiquitination | QLCLQQFPDIPESVT HHHHHHCCCCCHHHH | 33.99 | 21890473 | |
| 494 | Ubiquitination | QLCLQQFPDIPESVT HHHHHHCCCCCHHHH | 33.99 | - | |
| 497 | Ubiquitination | LQQFPDIPESVTCAC HHHCCCCCHHHHHHH | 34.88 | 22817900 | |
| 518 | Ubiquitination | IGDDSLQETDVNMES CCCCCCCCCCCCHHH | 52.87 | - | |
| 518 | Ubiquitination | IGDDSLQETDVNMES CCCCCCCCCCCCHHH | 52.87 | 27667366 | |
| 556 | Ubiquitination | GFNPEEDKCNNCDQE CCCCCCCCCCCCCHH | 41.99 | 21963094 | |
| 566 | Ubiquitination | NCDQELNKKPQDETK CCCHHHHCCCCCCCC | 77.71 | 33845483 | |
| 567 | Ubiquitination | CDQELNKKPQDETKE CCHHHHCCCCCCCCC | 47.00 | 27667366 | |
| 573 | Ubiquitination | KKPQDETKESTSCPV CCCCCCCCCCCCCHH | 47.85 | 27667366 | |
| 575 | Phosphorylation | PQDETKESTSCPVVQ CCCCCCCCCCCHHHH | 27.46 | 20068231 | |
| 576 | Phosphorylation | QDETKESTSCPVVQK CCCCCCCCCCHHHHH | 35.13 | 28270605 | |
| 577 | Phosphorylation | DETKESTSCPVVQKR CCCCCCCCCHHHHHH | 26.21 | 28270605 | |
| 583 | 2-Hydroxyisobutyrylation | TSCPVVQKRAALLNA CCCHHHHHHHHHHHH | 32.18 | - | |
| 583 | Acetylation | TSCPVVQKRAALLNA CCCHHHHHHHHHHHH | 32.18 | 26051181 | |
| 583 | Ubiquitination | TSCPVVQKRAALLNA CCCHHHHHHHHHHHH | 32.18 | 27667366 | |
| 597 | Phosphorylation | AILHSAYSETFLLPH HHHHHHHCCCCCCHH | 29.85 | - | |
| 599 | Phosphorylation | LHSAYSETFLLPHLK HHHHHCCCCCCHHHC | 17.40 | - | |
| 619 | Phosphorylation | HITLFLKYLYFLYLK HHHHHHHHHHHHHHH | 14.58 | 21406692 | |
| 621 | Phosphorylation | TLFLKYLYFLYLKCS HHHHHHHHHHHHHCC | 6.61 | 21406692 | |
| 624 | Phosphorylation | LKYLYFLYLKCSENA HHHHHHHHHHCCCCC | 8.33 | 21406692 | |
| 676 | Ubiquitination | RLLINLYKLVKSQIS HHHHHHHHHHHHHHH | 50.39 | 21906983 | |
| 676 | Ubiquitination | RLLINLYKLVKSQIS HHHHHHHHHHHHHHH | 50.39 | 21890473 | |
| 676 | Acetylation | RLLINLYKLVKSQIS HHHHHHHHHHHHHHH | 50.39 | 26051181 | |
| 679 | Ubiquitination | INLYKLVKSQISVYS HHHHHHHHHHHHHHH | 47.26 | 22817900 | |
| 685 | Phosphorylation | VKSQISVYSELNKIE HHHHHHHHHHHHHEE | 6.94 | 27642862 | |
| 686 | Phosphorylation | KSQISVYSELNKIEV HHHHHHHHHHHHEEC | 33.19 | 29978859 | |
| 694 | Phosphorylation | ELNKIEVSFRELQKL HHHHEECHHHHHHHH | 13.04 | 26356563 | |
| 700 | Ubiquitination | VSFRELQKLNQEKNN CHHHHHHHHCHHCCC | 63.13 | 27667366 | |
| 705 | Ubiquitination | LQKLNQEKNNRGLYS HHHHCHHCCCCCCEE | 50.16 | - | |
| 712 | Phosphorylation | KNNRGLYSIEVLELF CCCCCCEEEEEEECC | 19.81 | 28348404 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NOL11_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NOL11_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NOL11_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| UTP15_HUMAN | UTP15 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...